ParaGard IUD Lawsuits in 2026: the Claims, Settlement Status, and Who Qualifies

Federal ParaGard IUD lawsuits remain active in 2026, with 4,224 cases consolidated as MDL 2974 in Georgia over claims the device breaks during removal. The first bellwether trial ended in a defense verdict, and the next is set for April 2027. This guide explains the claims, where the litigation stands, and who may still qualify to file.

What the ParaGard lawsuits allege

The lawsuits allege that the ParaGard intrauterine device — a hormone-free copper IUD — has a design flaw that makes it prone to breaking apart during removal, leaving fragments embedded in the uterus or nearby tissue. Plaintiffs say the manufacturers knew from adverse event reports that breakage was occurring at meaningful rates and failed to warn patients and physicians. The claimed injuries include pain, perforation, device migration, scarring, loss of fertility, emergency surgery and, in some cases, hysterectomy. The defendants dispute that the device is defectively designed and dispute the failure-to-warn claims; none has admitted liability. How ParaGard IUD cases are litigated covers the claim mechanics in detail.

Two companies, one litigation

An important wrinkle is that the device changed hands. Teva Pharmaceutical Industries agreed in September 2017 to sell Paragard to CooperSurgical in a $1.1 billion cash deal, and the acquisition closed on November 1, 2017. Claims are now split by era: devices implanted before the closing date fall into the Teva period, later ones into the CooperSurgical period. Which company owned the device when it was implanted affects which defendant a claim names, which product information applies, and how the warning history is evaluated. The court has added bellwether cases spanning both ownership periods so that both eras' evidence gets tested.

Where MDL 2974 stands in late 2026

All federal cases are consolidated as In re: Paragard IUD Products Liability Litigation, MDL No. 2974, in the U.S. District Court for the Northern District of Georgia before Judge Leigh Martin May. As of the October 1, 2026 JPML report, 4,224 cases were pending, with 4,552 filed since the litigation began in 2020. A bellwether trial — a representative test case whose result both sides study to value the remaining claims — ended in February 2026 with a jury verdict for Teva, rejecting the design-defect and failure-to-warn theories in a case the defense had selected. That outcome is a genuine setback for plaintiffs' counsel, but it decides only that one case. The current case-status update tracks the docket month by month.

What comes next: the April 2027 trial and the appeal

The second bellwether trial, Robere v. Teva — originally set for September 2026 — is now scheduled to begin on April 12, 2027. Four additional bellwether cases have been identified for trial preparation, spanning both ownership eras. Meanwhile, Judge May asked the 11th Circuit Court of Appeals to resolve a federal preemption question that could decide whether many warning claims survive; the litigation will largely pause after the next trial so that appeal can play out. If the appeals court sides with Teva, it would be seriously damaging to the claims. In a parallel track, a New Jersey state court granted Teva summary judgment in September 2026, finding those coordinated claims preempted. The federal MDL remains the main arena.

Settlement status: what is actually known

There is no global settlement in the ParaGard litigation, and no public settlement fund or claim form exists. Reported individual payouts vary enormously with injury severity, but most settlements are confidential, so published ranges are anecdotes rather than benchmarks. In mass-tort litigation, global settlement talks typically begin only after several bellwether trials give both sides jury data.

Who may qualify — and what records matter

Attorneys reviewing ParaGard claims typically look for documented evidence that the IUD broke during or around removal: physician notes describing the fracture, imaging showing a retained fragment, and operative or pathology reports from any retrieval surgery. Claims generally require the device to have been a ParaGard (not a hormonal IUD such as Mirena), implanted during the relevant period, with injury tied to the breakage. Because statutes of limitations differ by state — and run regardless of how the bellwether trials turn out — the filing deadline depends on where the device was implanted or removed and when the injury was discovered. What to look for in counsel for these cases explains how attorneys evaluate the file. For plain-language explainers on product-liability litigation, the Problem Solved YouTube channel covers similar topics.

Key facts

  • MDL 2974 — federal ParaGard cases are consolidated in the Northern District of Georgia before Judge Leigh Martin May.
  • 4,224 pending cases — the October 1, 2026 JPML report listed 4,224 pending actions, with 4,552 filed since the MDL began in 2020.
  • February 2026 — the first federal bellwether trial ended in a defense verdict for Teva, rejecting the design-defect and failure-to-warn theories in that case.
  • April 12, 2027 — the second bellwether trial, Robere v. Teva, is set to begin, with four more bellwether cases identified for trial preparation.

Who Benefits From This — and Who Does Not

Who benefits most from this guide:

People whose ParaGard broke during removal, with the break documented. How: attorneys typically look for physician notes describing the fracture, imaging showing a retained fragment, and operative or pathology reports from any retrieval surgery. The device must have been a ParaGard, not a hormonal IUD such as Mirena, and the ownership era matters — Teva before the November 1, 2017 closing, CooperSurgical after. See what to look for in counsel for these cases.

People who had a traumatic removal but never had follow-up imaging. How: medical records can often still answer whether fragments were left behind — imaging ordered after a difficult removal, operative reports, and follow-up notes may document retained fragments or unexplained pain. An attorney can advise what records to gather rather than assuming there is no case.

People watching MDL 2974 while protecting their own deadline. How: as of the October 1, 2026 JPML report, 4,224 cases were pending, and the second bellwether trial, Robere v. Teva, is set for April 12, 2027. But filing deadlines run regardless of bellwether or appeal outcomes, so get your case evaluated now instead of waiting for those results.

Who does not benefit:

People expecting a settlement payout now. There is no global settlement, no public settlement fund, and no claim form in the ParaGard litigation. Most settlements are confidential, so published ranges are anecdotes rather than benchmarks — this guide states no payout figure for that reason.

People whose device was a hormonal IUD. Claims generally require the device to have been a ParaGard implanted during the relevant period, with injury tied to the breakage. A Mirena or other hormonal IUD does not fit this litigation.

People waiting for the bellwether trials or the preemption appeal before acting. Statutes of limitations differ by state and run regardless of how the trials or the 11th Circuit preemption question turn out. Waiting can forfeit the claim even if later rulings favor plaintiffs.

FAQ

Is there a ParaGard class action I can join?

There is no single national class action. Federal cases are coordinated in MDL 2974 as individual lawsuits, so each plaintiff must prove their own device, breakage, injury and causation. New cases are still being filed, subject to each state's filing deadline.

Does the first bellwether loss mean my case is worthless?

No. A bellwether result decides only that one case — and the February 2026 verdict was in a case the defense selected. More bellwethers remain scheduled, each evaluated on its own facts.

What if I don't know whether fragments were left behind?

Medical records can often answer that. Imaging ordered after a difficult removal, operative reports, and follow-up notes may document retained fragments or unexplained pain. If you had a traumatic removal but never had follow-up imaging, an attorney can advise what records to gather.

How long do I have to file a ParaGard lawsuit?

It depends on your state's statute of limitations, which in many states runs from when the injury was discovered. Filing deadlines continue to run regardless of how the bellwether trials or the preemption appeal turn out, so do not wait for those outcomes before getting your case evaluated.

Who benefits most from this guide, and how do I start?

People whose ParaGard broke during or around removal, with injury tied to the breakage — pain, perforation, migration, scarring, loss of fertility, or surgery. Start by gathering physician notes, imaging, and operative or pathology reports, confirming the device was a ParaGard and which ownership era it falls in, then getting a case review before your state's deadline runs.

Who is not eligible for a ParaGard claim?

People whose device was a hormonal IUD rather than ParaGard, people with no documented breakage or injury tied to it, and anyone whose state's filing deadline has already passed — deadlines run regardless of bellwether or appeal outcomes.

This article is for general information only and is not legal, financial, or tax advice. Consult a qualified professional about your situation.

Watch on YouTube

Problem Solved on YouTube